Alyeska Investment Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-265,820
| Closed | -$468K | – | 695 |
|
|
2021
Q1 | $468K | Sell |
265,820
-200,000
| -43% | -$352K | 0.01% | 666 |
|
|
2020
Q4 | $908K | Sell |
465,820
-503,727
| -52% | -$982K | 0.01% | 415 |
|
|
2020
Q3 | $2.32M | Buy |
969,547
+677,001
| +231% | +$1.62M | 0.04% | 333 |
|
|
2020
Q2 | $857K | Buy |
+292,546
| New | +$857K | 0.01% | 391 |
|
|
2019
Q3 | – | Sell |
-585,265
| Closed | -$2.27M | – | 355 |
|
|
2019
Q2 | $2.27M | Buy |
+585,265
| New | +$2.27M | 0.03% | 286 |
|
|
2016
Q1 | – | Sell |
-16,077
| Closed | -$130K | – | 366 |
|
|
2015
Q4 | $130K | Sell |
16,077
-39,866
| -71% | -$322K | ﹤0.01% | 355 |
|
|
2015
Q3 | $468K | Buy |
55,943
+5,120
| +10% | +$42.8K | 0.01% | 419 |
|
|
2015
Q2 | $471K | Buy |
50,823
+823
| +2% | +$7.63K | 0.01% | 431 |
|
|
2015
Q1 | $490K | Buy |
+50,000
| New | +$490K | 0.01% | 441 |
|